Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 33, Issue 3, 2012, Pages 375-376

  Olitsky, Scott E ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EYE DROPS; SILVER NITRATE; TIMOLOL;

ADULT; ARTICLE; BLEEDING; CASE REPORT; CAUTERIZATION; EPISTAXIS; GENETIC DISORDER; HUMAN; LASER COAGULATION; MALE; NOISE POLLUTION; PRIORITY JOURNAL; TELANGIECTASIA;

ADRENERGIC BETA-ANTAGONISTS; DIAGNOSIS, DIFFERENTIAL; EPISTAXIS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TIMOLOL;

EID: 84860371097     PISSN: 01960709     EISSN: 1532818X     Source Type: Journal    
DOI: 10.1016/j.amjoto.2011.10.011     Document Type: Article

References (6)

1. S.E. Olitsky Hereditary hemorrhagic telangiectasia: diagnosis and management Am Fam Physician 82 2010 785 790
2. T.T. Karnezis, and T.M. Davidson Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia- associated epistaxis Laryngoscope 121 2011 636 638
3. V. Sans, E.D. de la Roque, and J. Berge Propranolol for severe infantile hemangiomas: follow-up report Pediatrics 124 2009 e423 e431
4. N. Ni, P. Langer, and R. Wagner Topical timolol for periocular hemangioma: report of further study Arch Ophthalmol 129 2011 377 379
5. C. Storch, and P. Hoeger Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Br J Dermatol 163 2010 269 274
6. H. Sadick, F. Riedel, and R. Naim Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression Haematologica 90 2005 818 828